Elon Musk's SpaceX confidentially filed for what could become a record-setting U.S. listing, drawing renewed attention to the sequence of steps companies follow before their shares appear on an exchange. The process from the initial submission to the first trade commonly takes between three and six months, depending on regulatory review speed and market conditions.
The U.S. Securities and Exchange Commission permits confidential filings. That option gives issuers discretion over whether to submit an initial draft privately to regulators or to make it publicly available immediately. For large or sensitive companies, confidential submission can keep detailed financials and competitive information out of the public domain while the SEC examines the filing.
Initial filing and underwriting
In the months before an offering, a company appoints a syndicate of investment banks to act as underwriters. These banks are responsible for managing the mechanics of the deal, assessing investor appetite and helping set expectations for the prospective size of the sale. Once the underwriters are engaged, the company typically enters a quiet period during which public communications are restrained to avoid influencing investor demand prior to pricing.
The underwriters and company prepare a prospectus. High-profile issuers frequently file this prospectus confidentially so that the SEC can privately review it for any deficiencies or questions without exposing commercially sensitive material. After internal SEC review is completed to its satisfaction, the company files a public registration statement that incorporates the prospectus. U.S.-incorporated companies use a filing known as an S-1, while foreign issuers seeking a U.S. listing file an F-1. This public registration gives investors detailed information on the business, risk factors, major backers, significant shareholders and the chosen exchange and ticker.
Roadshow, sizing and marketing
When an issuer and its underwriters decide on a preliminary offering size, they file an amended registration statement - commonly labeled S-1/A or F-1/A - that discloses the number of shares proposed for sale and an indicative price range. The prospective raise is calculated by multiplying the number of shares being offered by the high end of the indicated price range. This step effectively reveals the potential valuation a company is targeting in the IPO.
Following that filing, company executives and underwriters embark on a roadshow to present the company to prospective investors and to test demand. Strong early interest can prompt a second amendment to the registration statement to increase the share count or to widen or raise the price range. If demand proves tepid, the opposite adjustments may be made - reducing the number of shares on offer or lowering the price range.
Pricing, allocation and market debut
Once underwriters complete their bookbuilding and determine the final offer price, the offering is priced and the sale portion of the process ends. The issuer may sell more or fewer shares than initially indicated, and the final price can fall above or below the earlier range depending on investor demand.
After pricing, underwriters allocate shares to institutional investors. Allocation decisions reflect a mix of demand signals and existing relationships, and underwriters commonly favor long-term holders in these allocations. In some cases underwriters exercise a greenshoe option, which allows them to sell additional shares to satisfy excess demand and to provide support in early trading.
Certain transactions include cornerstone investors - typically large institutional buyers who agree to buy shares ahead of the listing. Their participation provides upfront demand and a measure of confidence in the issue.
Shares usually begin trading on an exchange the day after pricing. Market watchers often use the opening price relative to the IPO price as an immediate gauge of investor appetite. But observers also monitor performance over the ensuing weeks, as the initial listing day is not the sole indicator of market reception.
Company insiders are generally restricted by a lock-up period, most commonly spanning 90 days to 180 days, during which they are not permitted to sell their shares. The end of that lock-up window is another milestone that market participants watch closely.
This multi-stage journey - from confidential submission to public registration, roadshow engagement, pricing and allocation, and finally to the lock-up expiry - frames the lifecycle for a U.S. IPO. The timeline and outcomes are shaped by SEC review, investor demand assessed during bookbuilding, and market conditions at the time of pricing and debut.